Whitehawk Therapeutics (WHWK) Asset Utilization Ratio: 2020-2025
Historic Asset Utilization Ratio for Whitehawk Therapeutics (WHWK) over the last 4 years, with Mar 2025 value amounting to 0.18.
- Whitehawk Therapeutics' Asset Utilization Ratio fell 6.78% to 0.18 in Q1 2025 from the same period last year, while for Mar 2025 it was 0.18, marking a year-over-year decrease of 6.78%. This contributed to the annual value of 0.26 for FY2024, which is 66.64% up from last year.
- According to the latest figures from Q1 2025, Whitehawk Therapeutics' Asset Utilization Ratio is 0.18, which was down 45.20% from 0.33 recorded in Q4 2024.
- Whitehawk Therapeutics' 5-year Asset Utilization Ratio high stood at 0.48 for Q1 2021, and its period low was 0.08 during Q4 2022.
- Over the past 3 years, Whitehawk Therapeutics' median Asset Utilization Ratio value was 0.18 (recorded in 2025), while the average stood at 0.20.
- Its Asset Utilization Ratio has fluctuated over the past 5 years, first crashed by 91.27% in 2021, then surged by 122.56% in 2023.
- Whitehawk Therapeutics' Asset Utilization Ratio (Quarterly) stood at 0.08 in 2021, then declined by 4.35% to 0.08 in 2022, then soared by 122.56% to 0.18 in 2023, then soared by 86.06% to 0.33 in 2024, then dropped by 6.78% to 0.18 in 2025.
- Its last three reported values are 0.18 in Q1 2025, 0.33 for Q4 2024, and 0.27 during Q3 2024.